Loading...
1CM Inc.
EPIC.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.24
CA$0.00(0.00%)
1CM Inc. (EPIC.CN) Financial Performance & Income Statement Overview
Review 1CM Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
61.91%
↑ 61.91%
Operating Income Growth
428.93%
↑ 428.93%
Net Income Growth
167.40%
↑ 167.40%
Operating Cash Flow Growth
241.55%
↑ 241.55%
Operating Margin
1.65%
↑ 1.65%
Gross Margin
16.99%
↑ 16.99%
Net Profit Margin
2.51%
↑ 2.51%
ROE
6.03%
↑ 6.03%
ROIC
3.16%
↑ 3.16%
1CM Inc. (EPIC.CN) Income Statement & Financial Overview
Review 1CM Inc.'s (EPIC.CN) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $17.80M | $17.55M | $16.60M | $15.01M |
| Cost of Revenue | $14.19M | $13.87M | $13.34M | $14.19M |
| Gross Profit | $3.61M | $3.69M | $3.25M | $823810.00 |
| Gross Profit Ratio | $0.20 | $0.21 | $0.20 | $0.05 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.83M | $2.77M | $1.43M | $2.03M |
| Operating Expenses | $3.19M | $3.12M | $1.65M | $2.63M |
| Total Costs & Expenses | $17.39M | $16.98M | $14.73M | $14.89M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $193014.00 | $195005.00 | $371231.00 | $159752.00 |
| Depreciation & Amortization | $354021.00 | $327383.00 | $352103.00 | $309279.00 |
| EBITDA | $766532.00 | $898872.00 | $1.95M | $427679.00 |
| EBITDA Ratio | $0.04 | $0.05 | $0.12 | $0.03 |
| Operating Income | $412511.00 | $571489.00 | $1.60M | $118400.00 |
| Operating Income Ratio | $0.02 | $0.03 | $0.10 | $0.008 |
| Other Income/Expenses (Net) | -$193000.00 | -$195000.00 | $1.23M | -$160000.00 |
| Income Before Tax | $219497.00 | $376484.00 | $1.23M | -$41352.00 |
| Income Before Tax Ratio | $0.01 | $0.02 | $0.07 | -$0.003 |
| Income Tax Expense | -$18395.00 | -$31360.00 | $177631.00 | -$22914.00 |
| Net Income | $237892.00 | $407844.00 | $1.05M | -$18438.00 |
| Net Income Ratio | $0.01 | $0.02 | $0.06 | -$0.001 |
| EPS | $0.002 | $0.004 | $0.009 | -$0.00 |
| Diluted EPS | $0.002 | $0.004 | $0.009 | -$0.00 |
| Weighted Avg Shares Outstanding | $117.74M | $117.74M | $117.64M | $117.74M |
| Weighted Avg Shares Outstanding (Diluted) | $117.74M | $117.74M | $117.64M | $117.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan